Key Segmentation:
By Product
-
Single-Use Bioreactor Systems
-
Filtration Assemblies
-
Single-Use Accessories
-
Media Bags and Containers
By Cell Type
-
Mammalian Cells
-
Bacterial Cells
-
Yeast Cells
-
Insect Cells
-
Other Cell Types
By Molecule Type
-
Monoclonal Antibodies
-
Vaccines
-
Stem Cells
-
Gene Therapy Products
-
Other Biologics
By Application
-
Biopharmaceutical Production
-
Research and Development
-
Cell and Gene Therapy Manufacturing
By End Use
-
Biopharmaceutical and Biotechnology Companies
-
Contract Manufacturing Organizations
-
Academic and Research Institutes
Regional Coverage:
North America
-
United States
-
Canada
Europe
-
Germany
-
United Kingdom
-
France
-
Italy
-
Spain
-
Russia
-
Poland
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization:
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Sartorius AG, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, and Getinge AB, among other bioprocessing equipment manufacturers.
Continued expansion into large-scale commercial production and continued development of bio-circular, sustainable single-use technology represent the primary opportunities.
Growth is primarily driven by rapid commercialisation of biologics, biosimilars, and cell and gene therapies, combined with substantial cost and operational efficiency advantages.
North America dominated the market with a 41.25% share in 2025, supported by strong biologics, vaccine, and cell and gene therapy investment.
By Product, Single-Use Bioreactor Systems dominated the market with a 42.15% share in 2025, reflecting their role as the foundational purchase for single-use biomanufacturing.